SUBSCRIBE
SUBSCRIBE
Leslie Zhen Liang

Leslie Zhen Liang

Leslie Zhen Liang is an award-winning investigative health and science journalist with a decade of experience covering medicine and health in China. He is now pursuing a master’s degree in Science, Health, and Environmental Reporting at NYU. He can be reached at zl5884@nyu.edu or on LinkedIn.

Two businesspeople handshake after good deal. US America and China flags on map. USA and China trade relations, cooperation strategy. vector illustration
China
No longer a bargain pool, Chinese biotechs command higher premiums
Deal dynamics between Chinese biotechs and global pharma companies are changing fast, with the biotechs seeking higher upfront payments and the Big Pharmas seeking more expansive platform deals.
June 3, 2026
 · 
5 min read
 · 
Leslie Zhen Liang
Businessmans hand holding a red globe with the map of China, symbolizing international business, trade, global markets, global influence, economics, or Chinese business ventures
China
Big Pharma Provides Lifeline to Chinese Companies Struggling To Survive
Out-licensing drugs to multinational corporations is a natural step for Chinese biotechs, but the recent rise in deals is only scratching at the surface of partnership-ready biotechs in the region.
August 6, 2025
 · 
7 min read
 · 
Leslie Zhen Liang